Free Trial

Sartorius (SRTGR; NR, BBB S) {SRT GR Equity}

HEALTHCARE
  • Some notes of concern in earnings call on M&A & leverage targets - below - we'd price the curve to one notch lower/closer to pharma curves VTRS/Bayer till we see operating performance turnaround.
  • The 26's still screen tad cheap at Z+72/3.95% as do the longer VTRS 27s at Z+92/4%.
https://marketnews.com/sartorius-srtgr-nr-bbb-s-sr...
48 words

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.
  • Some notes of concern in earnings call on M&A & leverage targets - below - we'd price the curve to one notch lower/closer to pharma curves VTRS/Bayer till we see operating performance turnaround.
  • The 26's still screen tad cheap at Z+72/3.95% as do the longer VTRS 27s at Z+92/4%.
https://marketnews.com/sartorius-srtgr-nr-bbb-s-sr...